Pomeroy M, Moriarty M
Blackrock Clinic, Co. Dublin, Ireland.
Cytotechnology. 1993;12(1-3):385-91. doi: 10.1007/BF00744675.
Cellular resistance is a significant component of tumour treatment failure. More detailed understanding of resistance mechanisms has enabled us to plan circumvention strategies, though these are not yet in routine clinical use. Such resistance is, however, only one of several factors which render cure of advanced malignant disease difficult. It is important for researchers in this field to see not only therapeutic opportunities but also limitations of these approaches. It is hoped that increased cooperation between clinicians and scientists in the field of cellular resistance will yield further improvement in tumour response rates and cure.
细胞耐药性是肿瘤治疗失败的一个重要因素。对耐药机制更深入的了解使我们能够制定规避策略,尽管这些策略尚未在常规临床中使用。然而,这种耐药性只是使晚期恶性疾病难以治愈的几个因素之一。该领域的研究人员不仅要看到治疗机会,还要认识到这些方法的局限性,这一点很重要。希望细胞耐药性领域的临床医生和科学家之间加强合作,能进一步提高肿瘤反应率并实现治愈。